Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

China Sets Ambitious Growth Target for 2025, Prepares Stimulus Amid U.S. Tariff Pressures

by Team Lumida
March 6, 2025
in Macro
Reading Time: 4 mins read
A A
0
Premium Chinese Brands: Why Investors Are Losing Faith
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • China has set a 5% growth target for 2025, maintaining its ambitious goal despite U.S. tariffs and domestic economic challenges.
  • Policymakers are ready to deploy monetary and fiscal abilities, including interest rate cuts, reserve ratio reductions, and targeted stimulus for key sectors.
  • The government plans to boost consumption through childcare subsidies, personal loans, and support for industries like catering and elderly care.
  • Efforts to reduce local government debt and promote technological innovation are central to China’s long-term economic strategy.

What Happened?

China’s top economic officials announced plans to maintain a 5% growth target for 2025, signaling confidence despite external and domestic challenges. Finance Minister Lan Fo’an and People’s Bank of China (PBOC) Governor Pan Gongsheng outlined measures to support growth, including a moderately loose monetary policy, interest rate cuts, and expanded relending abilities for technology and innovation. The government also unveiled its highest fiscal deficit target in over three decades, indicating plans for increased public spending. To address sluggish domestic demand, officials proposed childcare subsidies, personal consumption loans, and support for key industries. Meanwhile, efforts to reduce local government debt and promote free trade agreements are underway to counter U.S. tariffs and global trade pressures.

Why It Matters?

China’s ambitious growth target reflects its determination to stabilize the economy amid rising U.S. tariffs, a property slump, and weak domestic demand. The focus on consumption-driven growth, supported by subsidies and loans, marks a shift from investment-heavy strategies. For investors, the government’s willingness to deploy stimulus measures and promote technological innovation signals opportunities in sectors like tech, infrastructure, and consumer goods. However, challenges such as demographic decline, local government debt, and geopolitical tensions with the U.S. pose risks to sustained growth. The emphasis on free trade agreements and export diversification highlights China’s strategy to mitigate external pressures.

What’s Next?

China is expected to roll out additional stimulus measures, including interest rate cuts and expanded relending programs, to support its growth target. Investors should watch for the government’s action plan to boost consumption and its impact on industries like childcare, catering, and elderly care. Trade data and broader economic figures set to be released later this month will provide further insights into the economy’s trajectory. Additionally, China’s efforts to sign free trade agreements and reduce local government debt will be critical in shaping its long-term economic resilience.

Source
Previous Post

Bitcoin Could Swing $5K After White House Crypto Summit, ETH and SOL Volatility Expected

Next Post

Mistral AI Challenges Industry Giants with Open-Source AI Models and European Expansion

Recommended For You

Dollar Steadies, Euro and Sterling Vulnerable as Markets Await Fed Decision; Bitcoin Trades at 4-Week Lows

by Team Lumida
2 hours ago
Dollar Steadies, Euro and Sterling Vulnerable as Markets Await Fed Decision; Bitcoin Trades at 4-Week Lows

Currencies position ahead of Fed rate hike; dollar strength pressures EUR, GBP, AUD; Bitcoin at $75,886 after Clarity Act fails; forward guidance key to currency moves.

Read more

Bank of England Eyes End to Long-Dated Bond Sales as 30-Year Gilts Approach 6%, Shifting Quantitative Tightening Strategy

by Team Lumida
1 day ago
Bank of England Eyes End to Long-Dated Bond Sales as 30-Year Gilts Approach 6%, Shifting Quantitative Tightening Strategy

The BOE may cease selling 20 and 30-year bonds despite heavy losses, marking a reversal of recent messaging as energy prices and inflation expectations pressurize sterling debt.

Read more

10-Year Treasury Yield Hits 5.025%, Highest Since 2007, as Markets Price 92% Odds of Fed Hike

by Team Lumida
1 day ago
10-Year Treasury Yield Hits 5.025%, Highest Since 2007, as Markets Price 92% Odds of Fed Hike

The 10-year yield surged to 5.025% as inflation remains above the Fed's target, with traders betting heavily on a 25-basis-point rate increase this week.

Read more

BIS Warns Leveraged Hedge Funds Pose Growing Systemic Risk After Situational Awareness Near-Collapse

by Team Lumida
2 days ago
BIS Warns Leveraged Hedge Funds Pose Growing Systemic Risk After Situational Awareness Near-Collapse

The Bank for International Settlements flagged the July near-collapse of Leopold Aschenbrenner's AI-focused hedge fund as evidence that leveraged funds have become a core financial stability risk.

Read more

Study Finds Trump’s Drug-Pricing Push Incentivizes Higher Prices and Reduced Access Outside the US

by Team Lumida
2 days ago
Study Finds Trump’s Drug-Pricing Push Incentivizes Higher Prices and Reduced Access Outside the US

A Lancet study found that for roughly three in four drugs studied, matching US Medicare prices to cheaper reference countries would cost companies more than they earn in...

Read more

Chevron Says It Needs EU Methane Rule Clarity Before Committing to LNG Import Infrastructure

by Team Lumida
2 days ago
Chevron Says It Needs EU Methane Rule Clarity Before Committing to LNG Import Infrastructure

Chevron is weighing investment in European LNG regasification capacity but wants clearer methane regulations before making long-term commitments, its global gas president said.

Read more

Russia Outpaces US and NATO on Cheap Weapons Production, Fueled by Chinese Components

by Team Lumida
2 days ago
Russia Outpaces US and NATO on Cheap Weapons Production, Fueled by Chinese Components

Russia has fielded new Geran drones and Banderol cruise missiles at roughly $100,000 each, built on Chinese electronics, faster than Ukraine or Western militaries can match.

Read more

10-Year Treasury Yield Holds Near 4.97% as Markets Price 86.7% Odds of a Fed Hike This Week

by Team Lumida
2 days ago
Lumida Wealth Whale Watch Q2’24 : Macro Funds

Treasury yields were little changed Monday as investors weighed whether a move above 5% on the 10-year would come from healthy growth or from stress in the bond...

Read more

BMO and Sun Life Commit C$75 Billion to Canada’s Infrastructure Build, Days Before Carney’s Toronto Investor Summit

by Team Lumida
5 days ago
BMO and Sun Life Commit C$75 Billion to Canada’s Infrastructure Build, Days Before Carney’s Toronto Investor Summit

BMO pledged up to C$70 billion over a decade and Sun Life C$5 billion for Canadian infrastructure, ahead of Mark Carney's investor summit in Toronto.

Read more

10-Year Treasury Yield Hits 4.94%, Closest to 5% Since 2023 as Traders Price 70% Odds of a September Fed Hike

by Team Lumida
5 days ago
Saudi Arabia Leads $321B EM Bond Spree: What Investors Need to Know

The 10-year Treasury yield climbed to 4.94% ahead of August CPI, with traders pricing roughly 70% odds of a Fed rate hike on Sept. 16.

Read more
Next Post
Mistral AI Challenges Industry Giants with Open-Source AI Models and European Expansion

Mistral AI Challenges Industry Giants with Open-Source AI Models and European Expansion

Fed Official Warns of Inflation Risks Under Trump Presidency

German Factory Orders Plunge Amid Tariff Uncertainty and Economic Pressures

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Blackrock Q2 2024 Earnings Summary

Vanguard Dethrones BlackRock After 20 Years at the Top of the US ETF Market

June 12, 2026
Elon Musk Reignites Legal Battle Against OpenAI and Sam Altman

Elon Musk Reignites Legal Battle Against OpenAI and Sam Altman

August 5, 2024
Big Banks Set to Flood Market with Billions in Bonds

Big Banks Set to Flood Market with Billions in Bonds

October 11, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018